SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-032520
Filing Date
2014-09-23
Accepted
2014-09-23 13:21:06
Documents
1
Period of Report
2014-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd416570.html 4  
1 PRIMARY DOCUMENT rrd416570.xml 4 4664
  Complete submission text file 0001181431-14-032520.txt   6021
Mailing Address 1 STULTS DRIVE PLAINSBORO NJ 08536
Business Address
CAUWENBERGH GEERT (Reporting) CIK: 0001285648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 141115649

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations